Statistician Paul Meier, who championed the random assignment of patients to treatment groups in clinical trials, changed the way the researchers test experimental drugs.
The Scientist
Most Recent
When general practitioner John Lusingu returned to his native Tanzania to do research on malaria, he was met with a total lack of science infrastructure. Undeterred, he helped convert a former kitchen in the Korogwe District Hospital into a small mal
To ensure high-quality clinical trials of a malaria vaccine, organizers in rural Africa must first upgrade electrical and research infrastructures.
Proposed rules would streamline human research and strengthen protections for study subjects, according to the US government.
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
A new study confirms that a “trial effect”—in which patients improve simply as a result of taking part in a drug study—once existed among HIV trial participants.
A journal halts publication of a study on the benefits of meditation for heart disease to review additional data.
South Korea approves the first stem-cell medication for clinical use.
In contrast to yesterday’s news about the success of an HPV vaccine program in Australia, an Indian trial of the vaccine is stoking unfounded fear among the public and exposing some questionable ethical standards
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
